Coping with missing data in phase III pivotal registration trials: Tolvaptan in subjects with kidney disease, a case study

A Multiple Imputation Method for Sensitivity Analyses of Time-to-Event Data with Possibly Informative Censoring

(2014) Yue Zhao et al.   Journal of Biopharmaceutical Statistics

Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder

(2014) Dong-Jing Fu et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease

(2013) Wendy E. Boertien et al.   KIDNEY INTERNATIONAL

Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models

(2013) Bohdana Ratitch et al.   PHARMACEUTICAL STATISTICS

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

(2012) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

A structured approach to choosing estimands and estimators in longitudinal clinical trials

(2012) C. H. Mallinckrodt et al.   PHARMACEUTICAL STATISTICS

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

(2011) S. J. Pocock et al.   EUROPEAN HEART JOURNAL

Missing Data Issues at the FDA Center for Biologics Evaluation and Research

(2011) John A. Scott et al.   Journal of Biopharmaceutical Statistics

Missing Data in the Regulation of Medical Devices

(2011) Gregory Campbell et al.   Journal of Biopharmaceutical Statistics

Missing Data Handling Methods in Medical Device Clinical Trials

(2009) Xu Yan et al.   Journal of Biopharmaceutical Statistics